Navigation Links
Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees
Date:7/24/2009

PRINCETON, N.J., July 24 /PRNewswire/ -- Serious buyers and sellers of leading fine and custom chemical companies from around the world who gather at InformexUSA 2010 will experience even more focused, more efficient networking opportunities than in the past, allowing them to connect more precisely with others in their specific market.

The show opens February 16, 2010 in San Francisco, with a new agenda to reflect a targeted, but separate, focus on pharmaceutical and specialty chemical topics.

"The historic focus of Informex has been fine & specialty chemicals, custom chemical manufacturing, and related chemical materials and services," said Jennifer Jessup, Business Director, Informex.

"Exhibitors and attendees expressed the need for a show format tailored to their specific market; life science applications (pharma, biotech, agro) on the one hand and broader specialty and industrial chemicals, on the other. Our new segmented format is in response to that market need."

Informex Specialty programs will include:

* Specialty R&D Buyer Showcases featuring R&D speakers from key chemical companies.

* Chemical Licensing Breakfast Briefing presented by the Licensing Executives Society (LES).

* Green Chemistry Exchange showcasing sustainable and green chemistry products, technologies and services.

* Green Chemistry Breakfast Briefing developed in partnership with the ACS Green Chemistry Institute.

* Specialty Chemical Pavilion featuring companies serving the specialty and industrial chemical markets.

Informex Pharma programs will include:

* API Pavilion displaying Active Pharmaceutical Ingredient companies who service both generic and branded pharmaceuticals.

* Pharma Buyer Showcases to allow exhibitors to hear what their customers are looking for.

"We are happy to see Informex making a conscious effort to focus on specialty chemicals and getting back to the roots of the show. This is an under-represented market in US tradeshows and one we are happy to help grow,"

said Slaton Fry, Director at FutureFuel Chemical Company.

Informex is committed to providing the most valuable trade show for the fine and custom chemical industry and will continue to evaluate the current needs and wants of its exhibitors and attendees.

For more information on the upcoming show, please visit www.informex.com, or call Tom Leahy at 609-759-4731 or Devin Hader at 609-759-4746.

About Informex:

Organized by UBM International Media, Informex is the leading meeting place for buyers and sellers of high-value chemistry for a broad range of applications. As the leading fine chemical tradeshow in the United States, InformexUSA has been a marketplace for networking and doing business in the fine, custom and specialty chemical manufacturing industry for more than 25 years. Visitors to the show come from a broad range of manufacturing industries including adhesives, electronics, agrochemicals, biopharmaceuticals, pharmaceuticals, plastics, paints, and more. Each year the event brings together an international mix of more than 4,000 fine and specialty chemicals professionals and 500 exhibitors. For more information, visit www.informex.com

About UBM International Media (UBMi):

UBMi is a wholly owned subsidiary of United Business Media plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.unitedbusinessmedia.com


'/>"/>
SOURCE Informex
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Informex365.com is Launched for Manufacturers in Search of Chemical Reactions Expertise
2. Informex Opens Registration to InformexUSA 2009
3. InformexUSA 2009 Opens to Strong Attendance
4. Informex Survey Shows Innovation Remains a Priority for 2009 and Beyond
5. Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention
6. Angiotech to Establish Separate Operating and Royalty Businesses
7. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
8. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... May 22, 2017 , ... Baltimore ... of the Maryland Biohealth community in developing and issuing recommendations to grow Maryland's ... BioHealth Innovation Hub by 2023. , The recommendations are contained ...
(Date:5/19/2017)... Philadelphia, PA (PRWEB) , ... May 19, 2017 ... ... for its QED Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, ... Pennsylvania, New Jersey and Delaware, are encouraged to submit proposals. QED, now in ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... psychonneuroendocrine stress expertise, and further enhances its scientific power by providing investigators ... Granger, Ph.D., has agreed to join the scientific advisory board. “We are ...
(Date:5/18/2017)... ... 17, 2017 , ... Many complicated neurological disorders appear to ... disease, while men are at greater risk for Parkinson’s disease. Understanding some of ... aim of a research program at Worcester Polytechnic Institute (WPI) funded by a ...
Breaking Biology Technology:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
Breaking Biology News(10 mins):